Atomwise

Alumni
Series A


Digital Health

Website: www.atomwise.com
Total Funding: $51.30M
Funding Stage: Series A

Developer of a drug discovery platform designed to analyze new medicines. The company's platform helps in drug hit discovery, binding affinity prediction and toxicity detection, enabling scientists to discover small molecules for the treatment and investigation of human diseases.
Skip to toolbar